Skip to main content

Jorge Pagola Pérez Blanca

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Jorge Pagola Pérez Blanca

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

NexTOLL: A Phase IIb Clinical Trial to evaluate the neuroprotective effect of ApTOLL in stroke patients

IP: Marc Ribó Jacobi
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Carlos Molina Cateriano, Mª Ángeles Muchada López
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 498435
Reference: CPP2022- 009778
Duration: 09/03/2023 - 08/03/2026

Ministerio de Ciencia

VALIDACIÓN DIAGNÓSTICA DE UNA PULSERA INTELIGENTE PARA LA DETECCIÓN DE FIBRIL

IP: Jorge Pagola Pérez Blanca
Collaborators: Nuria Rivas Gandara, José Alvarez Sabin, Jaume Francisco Pascual
Funding agency: Instituto de Salud Carlos III
Funding: 85910
Reference: PI20/01210
Duration: 01/01/2021 - 30/06/2025

ITACAT: Impact of Thrombus Analysis in stroke patients in CATalonia.

IP: Carlos Molina Cateriano
Collaborators: Santiago Ramon y Cajal Agüeras, Jorge Pagola Pérez Blanca, Carlos Palacio García, Noelia Rodríguez Villatoro, David Rodriguez Luna
Funding agency: Fundació La Marató de TV3
Funding: 197973.69
Reference: 20171930
Duration: 01/01/2018 - 31/01/2022

Malalties Neurovasculars (GRC)

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 48000
Reference: 2014 SGR 686
Duration: 01/01/2014 - 31/12/2016

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Cañas Perea

Xavier Cañas Perea

Director/a d'Àrea
Clinical Research Development Directorate
Read more
Ruiz Esteve, Fernando

Ruiz Esteve, Fernando

Research technician
Neurovascular Diseases
Read more
Marcos Prieto, Susana

Marcos Prieto, Susana

Research technician
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.